Cleared Traditional

Nerve and Muscle Stimulator (K193276) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
302d
Days
Class 2
Risk

K193276 is an FDA 510(k) clearance for the Nerve and Muscle Stimulator. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Shenzhen Xft Medical Limited (Shenzhen, CN). The FDA issued a Cleared decision on September 23, 2020 after a review of 302 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Xft Medical Limited devices

Submission Details

510(k) Number K193276 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 2019
Decision Date September 23, 2020
Days to Decision 302 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 148d · This submission: 302d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Shenzhen Joyantech Consulting Co., Ltd.
Yoyo Chen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 17
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K193276.
MyndMove 2.0
K212149 · Myndtec, Inc. · Mar 2022
Cionic Neural Sleeve NS-100
K213622 · Cionic · Feb 2022
MStim Drop Model: LGT-233
K202110 · Guangzhou Longest Science & Technology Co., Ltd. · Nov 2021
L100 Go System
K200262 · Bioness, Inc. · Mar 2020
L360 Thigh System
K191587 · Bioness, Inc. · Sep 2019
L300 Go System
K190285 · Bioness, Inc. · Mar 2019